Vasilios K.
- Country
- Greece
- Department
- 1st Department of Neurology
Research Overview
- Phase 3 Randomized Double-Blind Trial of Riliprubart Versus Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Iptacopan in Patients with Generalized Myasthenia Gravis
- Efficacy and Safety of Nipocalimab in Adults with Chronic Inflammatory Demyelinating Polyneuropathy: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 149 of 277 partner sites.
Specializations
Neurological Disorders
This investigator specializes in treating complex neurological conditions, with particular emphasis on refractory focal onset epilepsy. Their research focuses on evaluating novel therapeutic approaches for patients who don't respond adequately to conventional treatments.
- Drug-resistant epilepsy management
- Focal seizure interventions
- Therapeutic efficacy assessment
Their work aims to expand treatment options for patients with medication-resistant seizures.
Neuromuscular Disorders
The investigator conducts research in generalized Myasthenia Gravis (gMG), focusing on innovative treatments to improve patients' daily living activities and overall quality of life.
- Autoimmune neuromuscular junction disorders
- Treatment optimization strategies
- Long-term disease management
Their research evaluates advanced therapeutic options for patients with chronic neuromuscular conditions.
Clinical Assessment
The investigator specializes in therapeutic efficacy evaluation through standardized assessment tools and patient-reported outcomes in neurological conditions.
- Safety and tolerability studies
- Clinical outcome measures
- Treatment response monitoring
Their expertise includes comprehensive evaluation of novel therapeutic interventions in neurological disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.